Stock A086820 BIO SOLUTION CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Bio Solution Co.,Ltd.

Equities

A086820

KR7086820008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 27/06/2024 BST 		5-day change 1st Jan Change
15,570 KRW +0.91% Intraday chart for Bio Solution Co.,Ltd. -0.13% -19.70%
2023 Helixmith Co., Ltd announced that it has received KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd. CI
2023 Helixmith Co., Ltd announced that it expects to receive KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Helixmith Co., Ltd announced that it has received KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.
CI
Helixmith Co., Ltd announced that it expects to receive KRW 36.57534969 billion in funding from Bio Solution Co.,Ltd.
CI
Bio Solution Co.,Ltd.(KOSDAQ:A086820) dropped from S&P Global BMI Index
CI
Biosolution Co.,Ltd. agreed to acquire 9.6% stake in Kyperion Co., Ltd. for KRW 4.5 billion.
CI
Bio Solution Co.,Ltd. announced that it has received KRW 42 billion in funding from Eum Private Equity, IBK Capital Corporation
CI
Bio Solution Co.,Ltd. announced that it has received KRW 60 billion in funding from Eum Private Equity, IBK Capital Corporation and other investors
CI
Bio Solution Co.,Ltd. announced that it expects to receive KRW 80 billion in funding from Eum Private Equity, IBK Capital Corporation
CI
Biosolution Co., Ltd.(KOSDAQ:A086820) added to S&P Global BMI Index
CI
Biosolution Co., Ltd. has completed an IPO in the amount of KRW 43.5 billion.
CI
Biosolution Co., Ltd. has filed an IPO.
CI
Biosolution Co., Ltd. has withdrawn its IPO.
CI
Biosolution Co., Ltd. has filed an IPO.
CI
MCTTBio Co.,Ltd. has withdrawn its IPO.
CI
Modern Cell & Tissue Technologies, Inc. announced that it has received KRW 4 billion in funding from Hyundai Venture Investment Corp. and Korea Investment Partners Co. Ltd.
CI
Modern Cell & Tissue Technologies, Inc. announced that it expects to receive KRW 4 billion in funding from Hyundai Venture Investment Corp. and Korea Investment Partners Co. Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A086820 Stock
  4. News Bio Solution Co.,Ltd.